406 related articles for article (PubMed ID: 21924945)
1. Modulation of innate immune responses during human T-cell leukemia virus (HTLV-1) pathogenesis.
Olière S; Douville R; Sze A; Belgnaoui SM; Hiscott J
Cytokine Growth Factor Rev; 2011 Aug; 22(4):197-210. PubMed ID: 21924945
[TBL] [Abstract][Full Text] [Related]
2. Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma.
Giusti RM; Maloney EM; Hanchard B; Morgan OS; Steinberg SM; Wachter H; Williams E; Cranston B; Fuchs D; Manns A
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):699-704. PubMed ID: 8877061
[TBL] [Abstract][Full Text] [Related]
3. Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis.
Tendler CL; Greenberg SJ; Burton JD; Danielpour D; Kim SJ; Blattner WA; Manns A; Waldmann TA
J Cell Biochem; 1991 Aug; 46(4):302-11. PubMed ID: 1757474
[TBL] [Abstract][Full Text] [Related]
4. Double control systems for human T-cell leukemia virus type 1 by innate and acquired immunity.
Kannagi M; Hasegawa A; Kinpara S; Shimizu Y; Takamori A; Utsunomiya A
Cancer Sci; 2011 Apr; 102(4):670-6. PubMed ID: 21219540
[TBL] [Abstract][Full Text] [Related]
5. The human T-cell leukemia virus type 1 (HTLV-1): new insights into the clinical aspects and molecular pathogenesis of adult T-cell leukemia/lymphoma (ATLL) and tropical spastic paraparesis/HTLV-associated myelopathy (TSP/HAM).
Shuh M; Beilke M
Microsc Res Tech; 2005 Nov; 68(3-4):176-96. PubMed ID: 16276549
[TBL] [Abstract][Full Text] [Related]
6. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N
J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and immunovirology of human T-cell leukemia/lymphoma virus type I-associated adult T-cell leukemia and chronic myelopathies as seen in France.
Gessain A; Gout O; Saal F; Daniel MT; Rio B; Flandrin G; Sigaux F; Lyon-Caen O; Periès J; de-Thé G
Cancer Res; 1990 Sep; 50(17 Suppl):5692S-5696S. PubMed ID: 2201441
[TBL] [Abstract][Full Text] [Related]
8. Tropical spastic paraparesis/human T leukemia virus type 1-associated myelopathy in HIV type 1-coinfected patients.
Beilke MA; Japa S; Moeller-Hadi C; Martin-Schild S
Clin Infect Dis; 2005 Sep; 41(6):e57-63. PubMed ID: 16107970
[TBL] [Abstract][Full Text] [Related]
9. Anti-Tax antibody levels in asymptomatic carriers, oligosymptomatic carriers, patients with rheumatologic disease or with HAM/TSP do not correlate with HTLV-1 proviral load.
de Souza JG; da Fonseca FG; Martins ML; Martins CP; de Carvalho LD; Coelho-dos-Reis JG; Carneiro-Proietti AB; Martins-Filho OA; Barbosa-Stancioli EF;
J Clin Virol; 2011 Jan; 50(1):13-8. PubMed ID: 20951636
[TBL] [Abstract][Full Text] [Related]
10. Immunopathogenesis of HTLV-1-assoaciated myelopathy/tropical spastic paraparesis (HAM/TSP).
Fuzii HT; da Silva Dias GA; de Barros RJ; Falcão LF; Quaresma JA
Life Sci; 2014 May; 104(1-2):9-14. PubMed ID: 24704970
[TBL] [Abstract][Full Text] [Related]
11. [Bronchopneumonopathy in HTLV-1 associated myelopathy (HAM) and non-HAM HTLV-1 carriers].
Maruyama I; Mori S; Kawabata M; Osame M
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 May; 30(5):775-9. PubMed ID: 1630040
[TBL] [Abstract][Full Text] [Related]
12. Human T cell leukemia virus type I and neurologic disease: events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation.
Grant C; Barmak K; Alefantis T; Yao J; Jacobson S; Wigdahl B
J Cell Physiol; 2002 Feb; 190(2):133-59. PubMed ID: 11807819
[TBL] [Abstract][Full Text] [Related]
13. HTLV-I serostatus of mothers of patients with adult T-cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis.
Bartholomew C; Jack N; Edwards J; Charles W; Corbin D; Cleghorn FR; Blattner WA
J Hum Virol; 1998; 1(4):302-5. PubMed ID: 10195256
[TBL] [Abstract][Full Text] [Related]
14. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
[TBL] [Abstract][Full Text] [Related]
15. Fucoidan therapy decreases the proviral load in patients with human T-lymphotropic virus type-1-associated neurological disease.
Araya N; Takahashi K; Sato T; Nakamura T; Sawa C; Hasegawa D; Ando H; Aratani S; Yagishita N; Fujii R; Oka H; Nishioka K; Nakajima T; Mori N; Yamano Y
Antivir Ther; 2011; 16(1):89-98. PubMed ID: 21311112
[TBL] [Abstract][Full Text] [Related]
16. Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers.
Ureta-Vidal A; Pique C; Garcia Z; Dehée A; Tortevoye P; Désiré N; Gessain A; Chancerel B; Gout O; Lemonnier FA; Cochet M
J Infect Dis; 2001 Mar; 183(6):857-64. PubMed ID: 11237801
[TBL] [Abstract][Full Text] [Related]
17. Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL.
Kannagi M; Hasegawa A; Nagano Y; Kimpara S; Suehiro Y
Retrovirology; 2019 Aug; 16(1):23. PubMed ID: 31438973
[TBL] [Abstract][Full Text] [Related]
18. Serum concentration and genetic polymorphism in the 5'-untraslated region of VEGF is not associated with susceptibility to HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-I infected individuals.
Saito M; Usuku K; Nobuhara Y; Matsumoto W; Kodama D; Sabouri AH; Izumo S; Arimura K; Osame M
J Neurol Sci; 2004 Apr; 219(1-2):157-61. PubMed ID: 15050452
[TBL] [Abstract][Full Text] [Related]
19. [Seropositivity of anti-HTLV-II antibodies in patients with HTLV-I-associated myelopathy and adult T-cell leukemia].
Nishimura Y; Yoshiki K; Yamaguchi K; Kiyokawa T; Takatsuki K
Rinsho Byori; 1991 Dec; 39(12):1351-2. PubMed ID: 1779473
[TBL] [Abstract][Full Text] [Related]
20. Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis.
Nozuma S; Kubota R; Jacobson S
J Neurovirol; 2020 Oct; 26(5):652-663. PubMed ID: 32705480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
